Making Strides in Covid-19 battle

India's Strides Pharma, whose unit will make Russia's Sputnik V vaccine, is emblematic of the country's strengths in biomedical science

Strides Pharma Global CEO Mohan Kumar says the Sputnik V contract is a vote of trust in Strides as well as an endorsement of the capabilities of the Indian pharma industry. ST PHOTO: KELVIN CHNG
New: Gift this subscriber-only story to your friends and family

Unlike its giant outsourcing companies such as Tata Consultancy Services and Infosys Technologies, India's pharmaceutical makers are a lot less understated in their public profiles even as they are the No. 1 supplier of generics globally.

Those who know something of the industry would recognise Sun Pharma, Cipla and Dr Reddy's Laboratories as among the better known names in a highly fragmented space. In the first quarter of this year, one firm that caught global attention was Bangalore-based Strides Pharma Science.

Already a subscriber? 

Read the full story and more at $9.90/month

Get exclusive reports and insights with more than 500 subscriber-only articles every month

Unlock these benefits

  • All subscriber-only content on ST app and straitstimes.com

  • Easy access any time via ST app on 1 mobile device

  • E-paper with 2-week archive so you won't miss out on content that matters to you

Join ST's Telegram channel and get the latest breaking news delivered to you.